Bionic pancreas successfully controls blood sugar levels in
adults, adolescents with type 1 diabetes
The latest version of a bionic pancreas device has been
successfully tested in two five-day clinical trials – one in adults, the other
in adolescents – that imposed minimal restrictions on patient activities.
The latest version of a bionic pancreas device has been
successfully tested in two five-day clinical trials – one in adults, the other
in adolescents – that imposed minimal restrictions on patient activities. A team of investigators from Boston
University (BU) and Massachusetts General Hospital (MGH) report study results
in a New England Journal of Medicine paper being issued online to coincide with
a presentation at the American Diabetes Association Scientific Sessions. The device controls blood sugar in patients
with type 1 diabetes using doses of both insulin and the blood-sugar-raising
hormone glucagon.